Induction Chemotherapy With Docetaxel and Nedaplatin Followed by Concurrent IMRT and Nedaplatin for Locally Advanced Nasopharyngeal Carcinoma

被引：2
|
作者：
Guan, X. [1 ]
Zhu, G. [1 ]
Wang, X. [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai 200433, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.05.1606
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2798
引用
收藏
页码：S525 / S526
页数：2
相关论文
共 50 条
  • [41] INDUCTION CHEMOTHERAPY WITH CARBOPLATIN AND TAXOL FOLLOWED BY RADIOTHERAPY AND CONCURRENT WEEKLY CARBOPLATIN plus TAXOL IN LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA
    Airoldi, Mario
    Gabriele, Anna Maria
    Garzaro, Massimiliano
    Raimondo, Luca
    Pedani, Fulvia
    Beatrice, Fabio
    Pecorari, Giancarlo
    Giordano, Carlo
    ANNALS OF ONCOLOGY, 2009, 20
  • [42] Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin plus taxol in locally advanced nasopharyngeal carcinoma
    Gabriele, A. M.
    Airoldi, M.
    Garzaro, M.
    Raimondo, L.
    Pedani, F.
    Beatrice, F.
    Pecorari, G.
    Giordano, C.
    EJC SUPPLEMENTS, 2009, 7 (02): : 486 - 486
  • [43] Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin plus taxol in locally advanced nasopharyngeal carcinoma
    Airoldi, Mario
    Gabriele, Pietro
    Gabriele, Anna Maria
    Garzaro, Massimiliano
    Raimondo, Luca
    Pedani, Fulvia
    Beatrice, Fabio
    Pecorari, Giancarlo
    Giordano, Carlo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (05) : 1027 - 1034
  • [44] Induction chemotherapy with cisplatin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a nonendemic population
    Airoldi, M.
    Garzaro, M.
    Gabriele, A.
    Raimondo, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [45] TPF induction chemotherapy followed by concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: Long term results of a Tunisian series
    Toumi, N.
    Ben Kridis, W.
    Mnejja, W.
    Bouzguenda, R.
    Khanfir, A.
    Ghorbel, A.
    Daoud, J.
    Frikha, M.
    CANCER RADIOTHERAPIE, 2018, 22 (03): : 216 - 221
  • [46] Which chemotherapy to associate with IMRT in locally advanced nasopharyngeal carcinoma?
    Nouri, Omar
    Ben Ali, Balkiss
    Mnejja, Wafa
    Fourati, Nejla
    Siala, Wicem
    Khanfir, Afef
    Sahnoun, Tarek
    Farhat, Leila
    Daoud, Jamel
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1415 - S1417
  • [47] Feasibility and activity of docetaxel, cisplatinum and 5-fluorouracil induction chemotherapy followed by concurrent chemo-radiotherapy (including IMRT) in locally advanced undifferentiated nasopharyngeal cancer (LANPC).
    Bossi, P.
    Orlandi, E.
    Locati, L.
    Bergamini, C.
    Liberatoscioli, C.
    Fallai, C.
    Palazzi, M.
    Olmi, P.
    Licitra, L.
    RADIOTHERAPY AND ONCOLOGY, 2007, 82 : S58 - S58
  • [48] Feasibility and activity of docetaxel, cisplatinum and 5-fluorouracil (TPF) induction chemotherapy followed by concurrent chemo-radiotherapy (including IMRT) in locally advanced nasopharyngeal cancer (LANPC)
    Bergamini, Cristiana
    Bossi, Paolo
    Orlandi, Ester
    Locati, Locati
    Liberatoscioli, Cecilia
    Fallai, Carlo
    Palazzi, Mauro
    Olmi, Patrizia
    Licitra, Lisa
    ANNALS OF ONCOLOGY, 2007, 18 : 83 - 83
  • [49] A PHASE II TRIAL OF INDUCTION CHEMOTHERAPY WITH CISPLATIN, DOCETAXEL AND CAPECITABINE FOLLOWED BY CONCURRENT CISPLATIN- RADIOTHERAPY IN ADVANCED NASOPHARYNGEAL CARCINOMA
    Yamouni, M.
    Beldjilali, Y.
    Benhadji, K. A.
    Boukerche, A.
    Khellafi, H.
    Abdelaoui, A.
    Betkaoui, F.
    Kaid, A.
    Benchlef, L.
    Djellali, L.
    ANNALS OF ONCOLOGY, 2010, 21 : 324 - 324
  • [50] Clinical value of docetaxel plus cisplatin (TP) induction chemotherapy followed by TP concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma
    Tao, Hao-Yun
    Zhan, Ze-Jiang
    Qiu, Wen-Ze
    Liao, Kai
    Yuan, Ya-Wei
    Yuan, Tai-Ze
    Zheng, Rong-Hui
    JOURNAL OF CANCER, 2021, 12 (01): : 18 - 27
12345